Lisinopril hctz clinical efficacy
Pro Research Analysisby 
Searched over 200M research papers
Clinical Efficacy of Lisinopril-Hydrochlorothiazide Combination in Hypertension
Blood Pressure Reduction: Lisinopril-HCTZ vs. Monotherapy
Multiple studies show that the fixed combination of lisinopril and hydrochlorothiazide (HCTZ) is more effective at lowering blood pressure than either drug alone. The combination leads to greater reductions in both systolic and diastolic blood pressure compared to monotherapy with either lisinopril or HCTZ, with a higher percentage of patients achieving target diastolic blood pressure (≤90 mm Hg) and a significant proportion experiencing a reduction of at least 10 mm Hg from baseline Lang1991Pool1987Kochar1987. This superior efficacy is consistent in both short-term (8–12 weeks) and long-term (up to 24 weeks) studies Pool1987Kochar1987.
Comparison with Other Antihypertensive Combinations
When compared to captopril plus HCTZ, the lisinopril-HCTZ combination generally produces a greater reduction in diastolic blood pressure and a higher rate of blood pressure normalization, although differences in systolic blood pressure reduction are less pronounced Rd1991Rappelli1991Rappelli1992+1 MORE. The lisinopril-HCTZ combination also provides more consistent 24-hour blood pressure control, as shown by ambulatory monitoring . In comparisons with HCTZ/amiloride, lisinopril alone achieves greater reductions in both systolic and diastolic blood pressure and a higher rate of patients reaching target blood pressure .
Efficacy in Special Populations
In elderly patients, both lisinopril and HCTZ are effective, but lisinopril is associated with fewer adverse effects and less reduction in serum potassium . In obese hypertensive patients, both lisinopril and HCTZ lower blood pressure, but lisinopril is more effective in certain subgroups, such as men and white patients, and in those with a "dipper" blood pressure profile .
Tolerability and Safety Profile
The lisinopril-HCTZ combination is generally well tolerated. While adverse effects are slightly more common with the combination than with lisinopril alone, they are not more frequent than with HCTZ monotherapy or other combinations like captopril-HCTZ Lang1991Rd1991Rappelli1991+2 MORE. Laboratory changes include a decrease in potassium and an increase in uric acid with the combination, but cholesterol levels may decrease, which is favorable compared to HCTZ alone . Serious adverse events are rare, and most side effects are mild and resolve spontaneously .
Long-Term Efficacy and Maintenance
Long-term studies up to 52 weeks confirm that the lisinopril-HCTZ combination maintains effective blood pressure control in the majority of patients, with a high proportion sustaining target diastolic blood pressure and significant reductions from baseline Pool1987Kochar1987. The combination remains effective and safe for extended use.
Conclusion
The combination of lisinopril and hydrochlorothiazide is a clinically effective and well-tolerated option for treating mild to moderate hypertension. It consistently outperforms monotherapy with either agent and is at least as effective, if not superior, to other common antihypertensive combinations. The combination is effective across various patient populations and maintains its efficacy and safety in long-term use.
Sources and full results
Most relevant research papers on this topic